Outcome in 146 patients with paediatric acute myeloid leukaemia treated according to the AML99 protocol in the period 2003-06 from the Japan Association of Childhood Leukaemia Study-Reference-Cited by-同舟云学术

Outcome in 146 patients with paediatric acute myeloid leukaemia treated according to the AML99 protocol in the period 2003-06 from the Japan Association of Childhood Leukaemia Study

Published:2012-08-28 Issue:2 Volume:159 Page:204-210
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Imamura Toshihiko¹,Iwamoto Shotaro²,Kanai Rie³,Shimada Akira⁴,Terui Kiminori⁵,Osugi Yuko⁶,Kobayashi Ryoji⁷,Tawa Akio⁸,Kosaka Yoshiyuki⁹,Kato Koji¹⁰,Hori Hiroki²,Horibe Keizo¹¹,Oda Megumi¹²,Adachi Souichi¹³,

Affiliation:

1. Department of Paediatrics; Kyoto Prefectural University of Medicine; Graduate School of Medical Science; Kyoto; Japan

2. Department of Paediatrics; Mie University; Tsu; Japan

3. Department of Paediatrics; Shimane University; Matsue; Japan

4. Department of Paediatrics; Nagoya University; Nagoya; Japan

5. Department of Paediatrics; Hirosaki University; Hirosaki; Japan

6. Department of Paediatric Haematology/Oncology; Osaka City General Hospital; Osaka; Japan

7. Department of Paediatrics; Sapporo Hokuyu Hospital; Sapporo; Japan

8. Department of Paediatrics; National Hospital Organization Osaka National Hospital; Osaka; Japan

9. Department of Haematology/Oncology; Hyogo Prefectural Children's Hospital; Kobe; Japan

10. Department of Haematology Oncology; Children's Medical Centre, Japanese Red Cross Nagoya First Hospital; Nagoya; Japan

11. Clinical Research Centre; National Hospital Organization Nagoya Medical Centre; Nagoya; Japan

12. Department of Paediatrics; Okayama University; Okayama; Japan

13. Human Health Sciences; Kyoto University; Kyoto; Japan

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12030/fullpdf

Reference17 articles.

1. Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia;Balgobind;Haematologica,2011

2. Minimally differentiated acute myeloid leukemia (FABAML-M0) is associated with an adverse outcome in children: a report from the Children's Oncology Group, studies CCG-2891 and CCG-2961;Barbaric;Blood,2007

3. Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials;Gibson;Leukemia,2005

4. Results of a randomized trial in children with acute myeloid leukaemia: Medical Research Council AML12 trial;Gibson;British Journal of Haematology,2011

5. Favorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AML;Hollink;Leukemia,2009

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Factors of Pediatric Acute Myeloid Leukemia Patients with t(8;21) (q22;q22): A Single-Center Retrospective Study;Children;2024-05-17

2. Supportive care in pediatric acute myeloid leukemia:Expert-based recommendations of the NOPHO-DB-SHIP consortium;Expert Review of Anticancer Therapy;2022-10-28

3. The outcomes of children with acute myeloid leukemia treated in accordance with the AML–MM-2006 protocol;Pediatric Hematology/Oncology and Immunopathology;2022-03-27

4. A Severe Form of COVID-19 in an Infant with Underlining Undiagnosed Acute Myeloid Leukemia;Journal of Biosciences and Medicines;2022

5. Results of a phase 2, multicenter, single‐arm, open‐label study of lenalidomide in pediatric patients with relapsed or refractory acute myeloid leukemia;Pediatric Blood & Cancer;2021-03-10